Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 66Pancreatic Neoplasms 35Neuroblastoma 21Neoplasm Metastasis 21Neoplasms 16Colonic Neoplasms 15Stomach Neoplasms 14Rectal Neoplasms 13Esophageal Squamous Cell Carcinoma 9Sarcoma, Ewing 8Rhabdomyosarcoma 8Small Cell Lung Carcinoma 7Sarcoma 7Ovarian Neoplasms 6Lung Neoplasms 6Cholangiocarcinoma 6Esophageal Neoplasms 5Breast Neoplasms 5Adenocarcinoma Of Esophagus 5Medulloblastoma 4Endometrial Neoplasms 4Biliary Tract Neoplasms 4Adenocarcinoma 4Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Osteosarcoma 3Locally Advanced Rectal Cancer 3Glioma 3Glioblastoma 3Gastrointestinal Neoplasms 3

Interventions

Therapeutic Irrigation 1Specimen Handling 1Pancreatectomy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ipilimumab 1Gemcitabine 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Acinar Cell × Irinotecan × 1 year × Clear all
NCT04657068 2026-03-18

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Artios Pharma Ltd

Phase 1/2 Recruiting
442 enrolled
GastrointestinalGynecologic

Fallopian Tube Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Acinar Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡